PERSONALIS INC (PSNL:NASDAQ)
$15.39 -0.19 (-1.2195%)
Analysed PERSONALIS INC (PSNL:NASDAQ) News Sources
Personalis Q1 Earnings Call Highlights
08-05-2026
marketbeat.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
13-05-2026
yahoo.com
Sector Update: Healthcare Stocks Mixed Late Afternoon
20-05-2026
yahoo.com
Assessing Personalis (PSNL) Valuation After Its Strong Recent Share Price Momentum
01-06-2026
yahoo.com
Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026
02-06-2026
yahoo.com
Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors?
04-06-2026
fool.com
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
09-06-2026
yahoo.com
Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain
14-07-2026
yahoo.com
Why Is PSNL Stock Up 5% After-Hours?
16-07-2026
stocktwits.com
Merck Reportedly Goes To Bat In Takeover Battle. But Genomics Stock Reverses.
17-07-2026
yahoo.com
What is the current price of PERSONALIS INC (PSNL:NASDAQ)?
The current price of PERSONALIS INC (PSNL:NASDAQ) is $15.39.
PERSONALIS INC (PSNL:NASDAQ) absolute price change since previous trading day?
The absolute price change of PERSONALIS INC (PSNL:NASDAQ) since the previous trading day is $-0.19.
PERSONALIS INC (PSNL:NASDAQ) percentage price change since previous trading day?
The percentage price change of PERSONALIS INC (PSNL:NASDAQ) since the previous trading day is -1.2195%.
What is the most recent average sentiment score for PERSONALIS INC (PSNL:NASDAQ)?
The most recent average sentiment score for PERSONALIS INC (PSNL:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for PERSONALIS INC (PSNL:NASDAQ)?
The most recent sentiment for PERSONALIS INC (PSNL:NASDAQ) is .
SEC-8K** Filing Available For PERSONALIS INC (PSNL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.